VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $679,000 | -73.2% | 100,000 | -61.0% | 0.10% | -67.5% |
| Q3 2022 | $2,536,000 | -9.4% | 256,696 | 0.0% | 0.31% | -26.8% |
| Q2 2022 | $2,798,000 | -3.6% | 256,696 | 0.0% | 0.42% | -26.9% |
| Q1 2022 | $2,903,000 | +57.0% | 256,696 | +34.1% | 0.58% | +73.4% |
| Q3 2020 | $1,849,000 | -15.6% | 191,426 | 0.0% | 0.34% | +57.3% |
| Q2 2020 | $2,190,000 | -29.5% | 191,426 | -36.1% | 0.21% | -51.1% |
| Q1 2020 | $3,106,000 | – | 299,800 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |